|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.65 HKD | +1.56% |
|
+8.33% | +6.56% |
| Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
| Feb. 29 | Yixin Group Logs 50% Rise in Fiscal 2023 Profit | MT |
Yixin Group Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was CNY 6,685.97 million compared to CNY 5,201.51 million a year ago. Net income was CNY 554.96 million compared to CNY 370.81 million a year ago.
Basic earnings per share from continuing operations was CNY 0.086 compared to CNY 0.058 a year ago. Diluted earnings per share from continuing operations was CNY 0.083 compared to CNY 0.056 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.56% | 542M | |
| +0.56% | 2.59B | |
| +11.92% | 2.16B | |
| -4.30% | 1.12B | |
| +9.82% | 741M | |
| -.--% | 314M | |
| -7.07% | 281M | |
| +3.16% | 238M | |
| +5.08% | 185M | |
| +29.91% | 183M |
YIXIN GROUP LIMITED 
